Concord Medical Services Holdings Limited (CCM)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26	23	48	71	87	119
Market Cap Growth	-51.09%	-51.09%	-32.93%	-18.00%	-27.00%	2.76%
Enterprise Value	517	1,027	1,010	1,120	1,028	785
Last Close Price	6.00	5.38	11.00	16.40	20.00	27.40
PS Ratio	0.50	0.44	0.63	1.04	1.14	3.48
PB Ratio	0.12	0.11	0.19	0.24	0.20	0.32
PEG Ratio	-	1.13	1.13	1.13	1.13	1.13
EV/Sales Ratio	9.82	19.53	13.32	16.36	13.45	22.99
Debt / Equity Ratio	2.43	2.43	1.89	1.61	1.00	0.98
Asset Turnover	0.06	0.06	0.09	0.08	0.08	0.05
Inventory Turnover	12.55	12.55	9.81	10.16	18.18	16.18
Quick Ratio	0.19	0.19	0.07	0.26	0.34	0.91
Current Ratio	0.46	0.46	0.32	0.68	0.73	1.32
Return on Equity (ROE)	-38.76%	-38.76%	-28.23%	-32.31%	-20.32%	-18.83%
Return on Assets (ROA)	-5.21%	-5.21%	-4.80%	-5.36%	-4.95%	-3.99%
Return on Capital (ROIC)	-6.28%	-6.28%	-5.62%	-6.12%	-5.60%	-4.52%
Earnings Yield	-162.11%	-180.79%	-87.89%	-99.70%	-49.20%	-39.92%
FCF Yield	-424.99%	-468.30%	-115.80%	-122.27%	-203.02%	-94.57%
Buyback Yield / Dilution	-	-	-	-	-	-0.63%

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q